Sponsored message
Logged in as
Audience-funded nonprofit news
radio tower icon laist logo
Next Up:
0:00
0:00
Subscribe
  • Listen Now Playing Listen
  • Listen Now Playing Listen
NPR News

Researchers: New Explanation For Alzheimer's

This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today.

Listen 0:00

There is growing evidence that small clusters of a protein called amyloid beta are what cause brain damage in Alzheimer's disease.

Scientists at the annual meeting of the Society for Neuroscience in Washington, D.C., say clusters of just two or three amyloid beta protein molecules can damage synapses, the connections between brain cells.

New research also shows that plaques of amyloid beta — much larger groupings made up of millions of cells — are not nearly as harmful as the small clusters.

Until the past couple of years, amyloid beta plaques were considered the most likely cause of Alzheimer's brain damage.

But Dennis Selkoe, a professor of neurology at Harvard Medical School, said the new findings suggest that hypothesis is wrong.

He presented research using various forms of amyloid beta protein taken from the brains of people with Alzheimer's disease. The proteins were injected into the brains of healthy rats.

Selkoe said entire plaques did not affect synapses. Neither did single proteins.

Sponsored message

"But you could inject the doublets and triplets into the brain of a healthy rat and show that the rat got forgetful," Selkoe said.

Selkoe's results were bolstered by a Swedish study that found high levels of even larger clusters in the brains of people with Alzheimer's disease who had died.

Frida Ekholm Pettersson of Uppsala University in Sweden says her team found no clusters in healthy brains.

Also at the meeting, researchers from Duke University presented new evidence that it's possible to reverse Alzheimer's disease by removing amyloid beta protein from the brain.

Donna Wilcock described an experiment using a new mouse model of Alzheimer's created by a colleague at Duke. The mice develop a memory problem very much the way people with Alzheimer's do.

But when the mice received a vaccine against amyloid beta, their memory improved.

Wilcock says the approach may work because it causes the body's immune system to attack all forms of amyloid beta — including small clusters.

Sponsored message

Scientists are trying a similar approach in people.

Copyright 2022 NPR. To see more, visit https://www.npr.org.

You come to LAist because you want independent reporting and trustworthy local information. Our newsroom doesn’t answer to shareholders looking to turn a profit. Instead, we answer to you and our connected community. We are free to tell the full truth, to hold power to account without fear or favor, and to follow facts wherever they lead. Our only loyalty is to our audiences and our mission: to inform, engage, and strengthen our community.

Right now, LAist has lost $1.7M in annual funding due to Congress clawing back money already approved. The support we receive from readers like you will determine how fully our newsroom can continue informing, serving, and strengthening Southern California.

If this story helped you today, please become a monthly member today to help sustain this mission. It just takes 1 minute to donate below.

Your tax-deductible donation keeps LAist independent and accessible to everyone.
Senior Vice President News, Editor in Chief

Make your tax-deductible donation today